Effect of methamphetamine and fluoxetine combination on metabolic activity of CYP2D1 in isolated perfused liver

Homeostasis in Health and Disease

Volumn 42, Issue 1-2, 2003, Pages 86-89

  Dostalek M ^a   Sliva J ^a   Hadasova E ^a   Tomandl, J ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D1; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; FLUOXETINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME METABOLISM; LIVER PERFUSION; LIVER WEIGHT; MALE; NONHUMAN; OXYGEN CONSUMPTION; RAT;

EID: 33845703151     PISSN: 09607560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ballet FA, Thurman RG. In: Perfused Liver. Eds: F.A. Ballet & R.G. Thurman. John Libbey, London 1991, pp. 1-19
2. Cornelius JR, Salloum IM et al. Arch Gen Psychiatry. 1997;54(8):700-705
3. Jeppesen U, Gram LF et al. Eur J Clin Pharmacol. 1996;51:73-78
4. Kobayashi K, Yamamoto T et al. Br J Clin Pharmacol. 1995;40(Suppl 5):481-485
5. Lin LY, Kumagai Y et al. Drug Metab Dispos 1995;23:610-614.
6. Park YH, Kullberg MP et al. J Pharm Sci. 1984;73:24-29.
7. Slíva J, Hadašová E. Programme and abstracts. Soelden. 2002:70.
8. Sommi RW, Crismon ML et al. Pharmacotherapy. 1987;7:1-15.
9. von Moltke LL, Greenblatt DJ et al. J Clin Psychopharmacol. 1995;15:125-131.
10. Wong DT, Bymaster FP et al. Life Sci. 1995;57:411-441.
11. Zimová G, Chládek J et al. Chem Listy 2000;94:132-135.